Compare RDHL & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDHL | AMST |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 11.8M |
| IPO Year | N/A | 2020 |
| Metric | RDHL | AMST |
|---|---|---|
| Price | $1.01 | $1.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 60.0K | ★ 504.0K |
| Earning Date | 09-05-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,550,000.00 | $193,505.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 157.62 | 68.56 |
| 52 Week Low | $1.01 | $1.85 |
| 52 Week High | $6.98 | $5.18 |
| Indicator | RDHL | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 33.28 |
| Support Level | $1.10 | $2.05 |
| Resistance Level | $1.23 | $2.23 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 38.76 | 9.38 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.